Form 8-K - Current report:
SEC Accession No. 0001437749-24-030559
Filing Date
2024-10-03
Accepted
2024-10-03 08:00:10
Documents
15
Period of Report
2024-10-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pirs20241003_8k.htm   iXBRL 8-K 37752
2 EXHIBIT 99.1 ex_729446.htm EX-99.1 19485
  Complete submission text file 0001437749-24-030559.txt   198983

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pirs-20241003.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20241003_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20241003_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20241003_pre.xml EX-101.PRE 11585
17 EXTRACTED XBRL INSTANCE DOCUMENT pirs20241003_8k_htm.xml XML 2845
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 241349926
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)